CSTL Annual Current Liabilities
$47.67 M
+$11.54 M+31.94%
31 December 2023
Summary:
As of January 21, 2025, CSTL annual total current liabilities is $47.67 million, with the most recent change of +$11.54 million (+31.94%) on December 31, 2023. During the last 3 years, it has risen by +$26.79 million (+128.33%). CSTL annual current liabilities is now at all-time high.CSTL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Quarterly Current Liabilities
$44.30 M
+$4.84 M+12.27%
30 September 2024
Summary:
As of January 21, 2025, CSTL quarterly total current liabilities is $44.30 million, with the most recent change of +$4.84 million (+12.27%) on September 30, 2024. Over the past year, it has dropped by -$3.37 million (-7.07%). CSTL quarterly current liabilities is now -7.07% below its all-time high of $47.67 million, reached on December 31, 2023.CSTL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.9% | -7.1% |
| 3 y3 years | +128.3% | -7.1% |
| 5 y5 years | +607.5% | -7.1% |
CSTL Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.5% | -7.1% | +78.0% |
| 5 y | 5-year | at high | +211.8% | -7.1% | +190.3% |
| alltime | all time | at high | +813.0% | -7.1% | +739.8% |
Castle Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $44.30 M(+12.3%) |
| June 2024 | - | $39.45 M(+23.5%) |
| Mar 2024 | - | $31.96 M(-33.0%) |
| Dec 2023 | $47.67 M(+31.9%) | $47.67 M(+31.2%) |
| Sept 2023 | - | $36.32 M(+7.7%) |
| June 2023 | - | $33.72 M(+11.9%) |
| Mar 2023 | - | $30.14 M(-16.6%) |
| Dec 2022 | $36.13 M(+45.2%) | $36.13 M(+13.1%) |
| Sept 2022 | - | $31.94 M(+16.1%) |
| June 2022 | - | $27.52 M(-30.4%) |
| Mar 2022 | - | $39.52 M(+58.8%) |
| Dec 2021 | $24.89 M | $24.89 M(+18.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $20.99 M(+12.5%) |
| June 2021 | - | $18.65 M(+6.1%) |
| Mar 2021 | - | $17.58 M(-15.8%) |
| Dec 2020 | $20.88 M(+36.5%) | $20.88 M(-31.0%) |
| Sept 2020 | - | $30.24 M(+7.1%) |
| June 2020 | - | $28.24 M(+85.1%) |
| Mar 2020 | - | $15.26 M(-0.2%) |
| Dec 2019 | $15.29 M(+126.9%) | $15.29 M(+65.5%) |
| Sept 2019 | - | $9.24 M(-21.4%) |
| June 2019 | - | $11.75 M(+122.7%) |
| Mar 2019 | - | $5.27 M(-21.7%) |
| Dec 2018 | $6.74 M(+29.0%) | $6.74 M |
| Dec 2017 | $5.22 M | - |
FAQ
- What is Castle Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Castle Biosciences?
- What is Castle Biosciences annual current liabilities year-on-year change?
- What is Castle Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Castle Biosciences?
- What is Castle Biosciences quarterly current liabilities year-on-year change?
What is Castle Biosciences annual total current liabilities?
The current annual current liabilities of CSTL is $47.67 M
What is the all time high annual current liabilities for Castle Biosciences?
Castle Biosciences all-time high annual total current liabilities is $47.67 M
What is Castle Biosciences annual current liabilities year-on-year change?
Over the past year, CSTL annual total current liabilities has changed by +$11.54 M (+31.94%)
What is Castle Biosciences quarterly total current liabilities?
The current quarterly current liabilities of CSTL is $44.30 M
What is the all time high quarterly current liabilities for Castle Biosciences?
Castle Biosciences all-time high quarterly total current liabilities is $47.67 M
What is Castle Biosciences quarterly current liabilities year-on-year change?
Over the past year, CSTL quarterly total current liabilities has changed by -$3.37 M (-7.07%)